New York State Common Retirement Fund Cti Biopharma Corp Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$4.2 - $6.01 $69,006 - $98,744	-16,430 Reduced 25.37%	48,323 $203,000
Q4 2022 Jan 30, 2023	BUY	$4.45 - $6.17 $235 - $327	53 Added 0.08%	64,753 $389,000
Q3 2022 Nov 08, 2022	BUY	$5.36 - $7.43 $4,288 - $5,944	800 Added 1.25%	64,700 $377,000
Q2 2022 Aug 04, 2022	BUY	$3.55 - $6.27 $226,845 - $400,653	63,900 New	63,900 $381,000
Q2 2019 Aug 09, 2019	SELL	$0.8 - $1.03 $29,840 - $38,419	-37,300 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$3.81 - $5.26 $142,113 - $196,198	37,300 New	37,300 $186,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.